Literature DB >> 16470077

Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002.

Bernard M Y Cheung1, Kwok Leung Ong, Yu Bun Man, Karen S L Lam, Chu-Pak Lau.   

Abstract

The prevalence, awareness, treatment, and control of hypertension in the United States are analyzed using the National Health and Nutrition Examination Survey (NHANES) database covering the period 1988-2002. Mean body mass index was 26.1+/-0.1 kg/m2 in 1988-1991 and 27.9+/-0.2 kg/m2 in 2001-2002 (p < 0.001). In the same period, the prevalence of diabetes mellitus increased from 5.0% to 6.5% (p = 0.03). Diastolic blood pressure was 73.3+/-0.2 mm Hg in 1988-1991 and 71.6+/-0.4 mm Hg in 2001-2002 (p < 0.001). Among the 18-39 years and 60 years and older age groups, the prevalence of hypertension increased significantly since 1988-1991. Multiple regression shows age, body mass index, and being non-Hispanic black were significantly associated with hypertension. In the period 1988-2002, the percentage receiving treatment and the percentage with blood pressure controlled increased significantly. In 2001-2002, significantly more people with hypertension and diabetes reached a blood pressure target of <130/85 mm Hg. Overall, the control rates were low, especially among middle-aged Mexican-American men (8%).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16470077      PMCID: PMC8109484          DOI: 10.1111/j.1524-6175.2006.04895.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  24 in total

1.  Characteristics of patients with uncontrolled hypertension in the United States.

Authors:  D J Hyman; V N Pavlik
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

2.  Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.

Authors:  Janice G Douglas; George L Bakris; Murray Epstein; Keith C Ferdinand; Carlos Ferrario; John M Flack; Kenneth A Jamerson; Wendell E Jones; Julian Haywood; Randall Maxey; Elizabeth O Ofili; Elijah Saunders; Ernesto L Schiffrin; Domenic A Sica; James R Sowers; Donald G Vidt
Journal:  Arch Intern Med       Date:  2003-03-10

3.  Sample design: Third National Health and Nutrition Examination Survey.

Authors:  T M Ezzati; J T Massey; J Waksberg; A Chu; K R Maurer
Journal:  Vital Health Stat 2       Date:  1992-09

4.  Inadequate management of blood pressure in a hypertensive population.

Authors:  D R Berlowitz; A S Ash; E C Hickey; R H Friedman; M Glickman; B Kader; M A Moskowitz
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

5.  Treatment and control of hypertension in the community: a prospective analysis.

Authors:  Donald M Lloyd-Jones; Jane C Evans; Martin G Larson; Daniel Levy
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

6.  Prevalence of hypertension in Hispanic and non-Hispanic white populations.

Authors:  Carlos Lorenzo; Manuel Serrano-Rios; Maria T Martinez-Larrad; Rafael Gabriel; Ken Williams; Clicerio Gonzalez-Villalpando; Michael P Stern; Helen P Hazuda; Steven Haffner
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

7.  Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.

Authors:  P K Whelton; L J Appel; M A Espeland; W B Applegate; W H Ettinger; J B Kostis; S Kumanyika; C R Lacy; K C Johnson; S Folmar; J A Cutler
Journal:  JAMA       Date:  1998-03-18       Impact factor: 56.272

8.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.

Authors:  V L Burt; P Whelton; E J Roccella; C Brown; J A Cutler; M Higgins; M J Horan; D Labarthe
Journal:  Hypertension       Date:  1995-03       Impact factor: 10.190

9.  The burden of adult hypertension in the United States 1999 to 2000: a rising tide.

Authors:  Larry E Fields; Vicki L Burt; Jeffery A Cutler; Jeffrey Hughes; Edward J Roccella; Paul Sorlie
Journal:  Hypertension       Date:  2004-08-23       Impact factor: 10.190

10.  Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Authors:  Stevo Julius; Sverre E Kjeldsen; Michael Weber; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; Anthony Schork; Beverly Smith; Alberto Zanchetti
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

View more
  26 in total

1.  Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study.

Authors:  Maribel Salas; Catarina I Kiefe; Pamela J Schreiner; Yongin Kim; Lucia Juarez; Sharina D Person; O Dale Williams
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883

2.  Worldwide epidemic of hypertension.

Authors:  Arun Chockalingam; Norman R Campbell; J George Fodor
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

Review 3.  Expanding the definition of hypertension to incorporate global cardiovascular risk.

Authors:  Nitin Khosla; Henry R Black
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

Review 4.  Antihypertensive prescribing: do we have reason to celebrate?

Authors:  Barry L Carter
Journal:  Hypertension       Date:  2006-09-18       Impact factor: 10.190

5.  Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.

Authors:  Vivencio Barrios; Alessandro Boccanelli; Silke Ewald; Xavier Girerd; Anthony Heagerty; Jean-Marie Krzesinski; Robert Lins; José Rodicio; Thomas Stefenelli; Arend Woittiez; Michael Böhm
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

6.  Hypertension treatment and control rates: chart review in an academic family medicine clinic.

Authors:  Sara J Houlihan; Scot H Simpson; Andrew J Cave; Nigel W Flook; Mary E Hurlburt; Chris J Lord; Linda L Smith; Harvey H Sternberg
Journal:  Can Fam Physician       Date:  2009-07       Impact factor: 3.275

7.  Screening, treatment, and control of hypertension in US private physician offices, 2003-2004.

Authors:  Jun Ma; Randall S Stafford
Journal:  Hypertension       Date:  2008-03-17       Impact factor: 10.190

8.  Prevalence, Awareness, Treatment, and Control of Hypertension in Romania: Results of the SEPHAR Study.

Authors:  M Dorobantu; R O Darabont; E Badila; S Ghiorghe
Journal:  Int J Hypertens       Date:  2010-02-01       Impact factor: 2.420

9.  Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes.

Authors:  Kazuo Eguchi; Thomas G Pickering; Satoshi Hoshide; Joji Ishikawa; Shizukiyo Ishikawa; Joseph E Schwartz; Kazuyuki Shimada; Kazuomi Kario
Journal:  Am J Hypertens       Date:  2008-02-21       Impact factor: 2.689

10.  Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older.

Authors:  Margaret McDonald; Robin P Hertz; Alan N Unger; Michael B Lustik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-30       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.